Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

Roll-Over Study of Ivacaftor in Cystic Fibrosis Pediatric Subjects With a CF Transmembrane Conductance Regulator Gene (CFTR) Gating Mutation
A Phase 3, 2-Arm, Roll-Over Study to Evaluate the Long-term Safety and Pharmacodynamics of Ivacaftor Treatment in Pediatric Subjects With Cystic Fibrosis and a CFTR Gating Mutation
Status: Enrolling
Updated:  3/4/2016
mi
from
Vancouver,
Roll-Over Study of Ivacaftor in Cystic Fibrosis Pediatric Subjects With a CF Transmembrane Conductance Regulator Gene (CFTR) Gating Mutation
A Phase 3, 2-Arm, Roll-Over Study to Evaluate the Long-term Safety and Pharmacodynamics of Ivacaftor Treatment in Pediatric Subjects With Cystic Fibrosis and a CFTR Gating Mutation
Status: Enrolling
Updated: 3/4/2016
mi
from
Vancouver,
Click here to add this to my saved trials
Validation of Safety and Efficacy for Night Shift Therapy
Validation of Safety and Efficacy for Night Shift Therapy
Status: Enrolling
Updated:  3/4/2016
Complete Sleep Solutions
mi
from
Murrieta, CA
Validation of Safety and Efficacy for Night Shift Therapy
Validation of Safety and Efficacy for Night Shift Therapy
Status: Enrolling
Updated: 3/4/2016
Complete Sleep Solutions
mi
from
Murrieta, CA
Click here to add this to my saved trials
Burden of Obstructive Sleep Apnea in Stroke (BOSAST)
Burden of Obstructive Sleep Apnea in Stroke (BOSAST)
Status: Enrolling
Updated:  3/7/2016
UCSD
mi
from
San Diego, CA
Burden of Obstructive Sleep Apnea in Stroke (BOSAST)
Burden of Obstructive Sleep Apnea in Stroke (BOSAST)
Status: Enrolling
Updated: 3/7/2016
UCSD
mi
from
San Diego, CA
Click here to add this to my saved trials
ProspEctive First Evaluation in Chest Pain Trial
ProspEctive Randomized First Evaluation in Chest Pain Trial
Status: Enrolling
Updated:  3/7/2016
St. Luke's and Roosevelt Hospitals
mi
from
New York, NY
ProspEctive First Evaluation in Chest Pain Trial
ProspEctive Randomized First Evaluation in Chest Pain Trial
Status: Enrolling
Updated: 3/7/2016
St. Luke's and Roosevelt Hospitals
mi
from
New York, NY
Click here to add this to my saved trials
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated:  3/9/2016
Clinical Research Facility
mi
from
Birmingham, AL
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated: 3/9/2016
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated:  3/9/2016
Clinical Research Facility
mi
from
Aurora, CO
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated: 3/9/2016
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated:  3/9/2016
Clinical Research Facility
mi
from
Indianapolis, IN
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated: 3/9/2016
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated:  3/9/2016
Clinical Research Facility
mi
from
Boston, MA
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated: 3/9/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated:  3/9/2016
Clinical Research Facility
mi
from
Omaha, NE
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated: 3/9/2016
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated:  3/9/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated: 3/9/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated:  3/9/2016
Clinical Research Facility
mi
from
Seattle, WA
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated: 3/9/2016
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated:  3/9/2016
Clinical Research Facility
mi
from
Atlanta, GA
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated: 3/9/2016
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated:  3/9/2016
Clinical Research Facility
mi
from
Lexington, KY
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated: 3/9/2016
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated:  3/9/2016
Clinical Research Facility
mi
from
Detroit, MI
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated: 3/9/2016
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated:  3/9/2016
Clinical Research Facility
mi
from
Grand Rapids, MI
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated: 3/9/2016
Clinical Research Facility
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated:  3/9/2016
Clinical Research Facility
mi
from
Minneapolis, MN
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated: 3/9/2016
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated:  3/9/2016
Clinical Research Facility
mi
from
Kansas City, MO
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated: 3/9/2016
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated:  3/9/2016
Clinical Research Facility
mi
from
Pittsburgh, PA
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated: 3/9/2016
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated:  3/9/2016
Clinical Research Facility
mi
from
Charlottesville, VA
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated: 3/9/2016
Clinical Research Facility
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated:  3/9/2016
Clinical Research Facility
mi
from
Richmond, VA
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated: 3/9/2016
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated:  3/9/2016
mi
from
Vancouver,
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
A Phase 3, 2-Part, Open-Label Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are 2 Through 5 Years of Age and Have a CFTR Gating Mutation
Status: Enrolling
Updated: 3/9/2016
mi
from
Vancouver,
Click here to add this to my saved trials
Targeting Acute Congestion With Tolvaptan in Congestive Heart Failure
The Targeting Acute Congestion With Tolvaptan In Congestive Heart Failure Study
Status: Enrolling
Updated:  3/10/2016
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Targeting Acute Congestion With Tolvaptan in Congestive Heart Failure
The Targeting Acute Congestion With Tolvaptan In Congestive Heart Failure Study
Status: Enrolling
Updated: 3/10/2016
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Targeting Acute Congestion With Tolvaptan in Congestive Heart Failure
The Targeting Acute Congestion With Tolvaptan In Congestive Heart Failure Study
Status: Enrolling
Updated:  3/10/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Targeting Acute Congestion With Tolvaptan in Congestive Heart Failure
The Targeting Acute Congestion With Tolvaptan In Congestive Heart Failure Study
Status: Enrolling
Updated: 3/10/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Targeting Acute Congestion With Tolvaptan in Congestive Heart Failure
The Targeting Acute Congestion With Tolvaptan In Congestive Heart Failure Study
Status: Enrolling
Updated:  3/10/2016
Hennepin County Medical Center
mi
from
Minneapolis, MN
Targeting Acute Congestion With Tolvaptan in Congestive Heart Failure
The Targeting Acute Congestion With Tolvaptan In Congestive Heart Failure Study
Status: Enrolling
Updated: 3/10/2016
Hennepin County Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Electrical Activity of Diaphragm as a Means to Predict Extubation Success in Preterm Infants
A Prospective Study of Diaphragmatic Electrical Activity in Preterm Infants as a Means to Predict Extubation Success
Status: Enrolling
Updated:  3/10/2016
Dartmouth Hitchcock Medcial Center
mi
from
Lebanon, NH
Electrical Activity of Diaphragm as a Means to Predict Extubation Success in Preterm Infants
A Prospective Study of Diaphragmatic Electrical Activity in Preterm Infants as a Means to Predict Extubation Success
Status: Enrolling
Updated: 3/10/2016
Dartmouth Hitchcock Medcial Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Atorvastatin to Treat Pulmonary Sarcoidosis
Atorvastatin as a Disease Modifying Agent in Stage II and III Pulmonary Sarcoidosis: A Randomized, Double-Blind, Placebo-Controlled Trial
Status: Enrolling
Updated:  3/11/2016
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Atorvastatin to Treat Pulmonary Sarcoidosis
Atorvastatin as a Disease Modifying Agent in Stage II and III Pulmonary Sarcoidosis: A Randomized, Double-Blind, Placebo-Controlled Trial
Status: Enrolling
Updated: 3/11/2016
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated:  3/11/2016
University of Arizona College of Medicine
mi
from
Tucson, AZ
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated: 3/11/2016
University of Arizona College of Medicine
mi
from
Tucson, AZ
Click here to add this to my saved trials
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated:  3/11/2016
Children's Hospital and Research Center Oakland
mi
from
Oakland, CA
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated: 3/11/2016
Children's Hospital and Research Center Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated:  3/11/2016
UCSF Benioff Children's Hospital
mi
from
San Francisco, CA
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated: 3/11/2016
UCSF Benioff Children's Hospital
mi
from
San Francisco, CA
Click here to add this to my saved trials
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated:  3/11/2016
National Jewish Health
mi
from
Denver, CO
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated: 3/11/2016
National Jewish Health
mi
from
Denver, CO
Click here to add this to my saved trials
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated:  3/11/2016
Rush University Medical Center/Stroger Hospital
mi
from
Chicago, IL
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated: 3/11/2016
Rush University Medical Center/Stroger Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated:  3/11/2016
St. Louis Children's Hospital
mi
from
St. Louis, MO
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated: 3/11/2016
St. Louis Children's Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated:  3/11/2016
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated: 3/11/2016
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated:  3/11/2016
Rainbow Babies and Children's Hospital, Case Western Reserve University
mi
from
Cleveland, OH
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated: 3/11/2016
Rainbow Babies and Children's Hospital, Case Western Reserve University
mi
from
Cleveland, OH
Click here to add this to my saved trials
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated:  3/11/2016
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated: 3/11/2016
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated:  3/11/2016
University of Virginia Health System
mi
from
Charlottesville, VA
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated: 3/11/2016
University of Virginia Health System
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated:  3/11/2016
University of Wisconsin-Madison
mi
from
Madison, WI
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated: 3/11/2016
University of Wisconsin-Madison
mi
from
Madison, WI
Click here to add this to my saved trials
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated:  3/11/2016
Emory University
mi
from
Atlanta, GA
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated: 3/11/2016
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated:  3/11/2016
Children's Memorial Hospital
mi
from
Chicago, IL
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated: 3/11/2016
Children's Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated:  3/11/2016
Children's Hospital Boston
mi
from
Boston, MA
Acetaminophen Versus Ibuprofen in Children With Asthma
Acetaminophen vs. Ibuprofen in Children With Asthma
Status: Enrolling
Updated: 3/11/2016
Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Status: Enrolling
Updated:  3/14/2016
University of California, San Diego
mi
from
San Diego, CA
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Status: Enrolling
Updated: 3/14/2016
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Status: Enrolling
Updated:  3/14/2016
West Suburban Hospital
mi
from
Oak Park, IL
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Status: Enrolling
Updated: 3/14/2016
West Suburban Hospital
mi
from
Oak Park, IL
Click here to add this to my saved trials
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Status: Enrolling
Updated:  3/14/2016
Mayo Clinic Foundation
mi
from
Rochester, MN
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Status: Enrolling
Updated: 3/14/2016
Mayo Clinic Foundation
mi
from
Rochester, MN
Click here to add this to my saved trials
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Status: Enrolling
Updated:  3/14/2016
St. John's Mercy Medical Center
mi
from
St. Louis, MO
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Status: Enrolling
Updated: 3/14/2016
St. John's Mercy Medical Center
mi
from
St. Louis, MO
Click here to add this to my saved trials
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Status: Enrolling
Updated:  3/14/2016
Audie Murphy VA Medical Center & University Hospital
mi
from
San Antonio, TX
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Multi-center Clinical Trial of the Bard Silver-coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
Status: Enrolling
Updated: 3/14/2016
Audie Murphy VA Medical Center & University Hospital
mi
from
San Antonio, TX
Click here to add this to my saved trials
Vigabatrin for Treatment of Cocaine Dependence
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status: Enrolling
Updated:  3/14/2016
Addiction Treatment Clinic
mi
from
Little Rock, AR
Vigabatrin for Treatment of Cocaine Dependence
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status: Enrolling
Updated: 3/14/2016
Addiction Treatment Clinic
mi
from
Little Rock, AR
Click here to add this to my saved trials
Vigabatrin for Treatment of Cocaine Dependence
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status: Enrolling
Updated:  3/14/2016
St. Luke's Hospital Addiction Pharmacology Research Laboratory
mi
from
San Francisco, CA
Vigabatrin for Treatment of Cocaine Dependence
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status: Enrolling
Updated: 3/14/2016
St. Luke's Hospital Addiction Pharmacology Research Laboratory
mi
from
San Francisco, CA
Click here to add this to my saved trials
Vigabatrin for Treatment of Cocaine Dependence
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status: Enrolling
Updated:  3/14/2016
Friends Research Institute
mi
from
Torrance, CA
Vigabatrin for Treatment of Cocaine Dependence
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status: Enrolling
Updated: 3/14/2016
Friends Research Institute
mi
from
Torrance, CA
Click here to add this to my saved trials
Vigabatrin for Treatment of Cocaine Dependence
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status: Enrolling
Updated:  3/14/2016
Operation PAR
mi
from
Largo, FL
Vigabatrin for Treatment of Cocaine Dependence
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status: Enrolling
Updated: 3/14/2016
Operation PAR
mi
from
Largo, FL
Click here to add this to my saved trials
Vigabatrin for Treatment of Cocaine Dependence
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status: Enrolling
Updated:  3/14/2016
The Segal Institute of Clinical Research
mi
from
North Miami, FL
Vigabatrin for Treatment of Cocaine Dependence
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Status: Enrolling
Updated: 3/14/2016
The Segal Institute of Clinical Research
mi
from
North Miami, FL
Click here to add this to my saved trials